Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
Pages
▼
Tuesday, November 4, 2014
Jazz Beats And Raises Views; Regeneron Misses In Q3
Sales climbed 32% to $306.6 million, about $4 million above analysts' estimates. The company lifted its full-year EPS outlook to $8.20-$8.35, with the midpoint 15 cents above the previous range.
No comments:
Post a Comment